Physician profile
Deborah Covert
NPI 1013924653
$3,222.77
in general payments reported to CMS, 2019-2025
17 companies · $843 in 2025
The $843 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $643 · 2023: $732 · 2024: $1,004 · 2025: $843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,579.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $481.99 | 2023-2024 | Freestyle Libre 3, Cardiomems, Mitraclip |
| Actelion Pharmaceuticals US, INC. | $324.97 | 2023-2024 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals LP | $287.96 | 2022-2025 | Airsupra, Lokelma |
| Novo Nordisk INC | $228.55 | 2022-2025 | |
| Boston Scientific Corporation | $227.92 | 2023-2025 | Watchman Access System |
| Amgen INC. | $220.42 | 2022-2025 | |
| Corcept Therapeutics | $213.63 | 2024-2025 | Korlym |
| Insmed, INC. | $211.18 | 2025 | Arikayce |
| Abbvie INC. | $185.96 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $129.62 | 2022 | |
| Axonics, INC. | $118.05 | 2024 | Axonics, Bulkamid |
| Idorsia Pharmaceuticals US INC | $103.22 | 2023 | Quviviq |
| Gilead Sciences, INC. | $102.66 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.18 | 2024 | Jardiance |
| Lucid Diagnostics INC. | $100.43 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $96.50 | 2023 | |
| Abiomed | $88.53 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Covert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.